You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: October 31, 2024

Details for New Drug Application (NDA): 010721


✉ Email this page to a colleague

« Back to Dashboard


NDA 010721 describes ANTIVERT, which is a drug marketed by Casper Pharma Llc and is included in one NDA. It is available from twelve suppliers. Additional details are available on the ANTIVERT profile page.

The generic ingredient in ANTIVERT is meclizine hydrochloride. There are seventeen drug master file entries for this compound. Thirty-five suppliers are listed for this compound. Additional details are available on the meclizine hydrochloride profile page.
Summary for 010721
Tradename:ANTIVERT
Applicant:Casper Pharma Llc
Ingredient:meclizine hydrochloride
Patents:0
Pharmacology for NDA: 010721
Physiological EffectEmesis Suppression
Medical Subject Heading (MeSH) Categories for 010721
Suppliers and Packaging for NDA: 010721
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ANTIVERT meclizine hydrochloride TABLET, CHEWABLE;ORAL 010721 NDA AUTHORIZED GENERIC Rising Pharmaceuticals, Inc. 16571-660 16571-660-01 100 TABLET in 1 BOTTLE (16571-660-01)
ANTIVERT meclizine hydrochloride TABLET, CHEWABLE;ORAL 010721 NDA AUTHORIZED GENERIC Rising Pharmaceuticals, Inc. 16571-660 16571-660-50 500 TABLET in 1 BOTTLE (16571-660-50)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength50MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Approval Date:Jan 20, 1982TE:AARLD:Yes

Profile for product number 004

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Approval Date:Approved Prior to Jan 1, 1982TE:AARLD:Yes

Profile for product number 005

Active Rx/OTC/Discontinued:RXDosage:TABLET, CHEWABLE;ORALStrength25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:Yes

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.